Pharmaceutical companies Biontech plans to partner with 13 competitors to produce two billion doses of vaccine this year, the company’s CEO fears future pandemics will worsen

Five EU countries accuse the Union of “unfairly” distributing vaccines and demand a summit.

Pharmaceutical company Biontech is preparing a new production collaboration to achieve its goal of producing two billion doses of vaccine against the coronavirus this year, says newspaper The Wall Street Journal.

The collaboration would involve 13 pharmaceutical companies, of which the magazine mentions the pharmaceutical companies Novartis, Merck and Sanofi.

The problem with the collaboration may be that Biontech utilizes new complex technologies in the manufacture of its rna vaccine, which require special know-how and rare raw materials. Therefore, supply chains are also vulnerable to the export restrictions that the European Union, Britain and the United States have recently introduced.

Read also: How the new coronary vaccines work: The RNA vaccine contains the virus’s own genome, the virus carriers have already been used in cancer treatments

German Biontech developed the world’s first vaccine against coronavirus with the US pharmaceutical company Pfizer.

The company managing director Ugur Sahin warned the news agency on Saturday In an interview with Bloombergthat pandemics may be worse in the future than a coronavirus pandemic.

In his view, the goal should be for the production capacity of pharmaceutical companies and states to allow the entire world population to be vaccinated within three months of the vaccine being developed for the new virus.

“We are not prepared to prepare enough doses of vaccines for all the people in the world,” CEO Sahin told Bloomberg. To achieve this goal, cooperation between pharmaceutical companies and states should be strengthened, he said.

Biontech and Pfizer’s vaccine is also used in Finland.

CEO Suhin informed Bloomberg that next year, the companies will be able to produce three billion doses of the vaccine. They also supply a large part of the 400 million doses of vaccine ordered by the European Union, according to Bloomberg.

According to the Department of Health and Welfare, the Biontech and Pfizer vaccine is very effective in preventing severe coronavirus disease in particular and the companies are more than doubling in April The number of vaccines they delivered to Finland.

“After several initial difficulties, Pfizer and Biontech have delivered exactly what they have promised for several weeks. I would be confident that these amounts will also come, ”said an expert from the Department of Health and Welfare Mia Kontio last week.

EU countries In an open letter, Bulgaria, Austria, Latvia, Slovenia and the Czech Republic call for an EU summit on the distribution of coronavirus vaccines in the EU, according to AFP. According to countries, there are “huge differences” within the EU in how much vaccines they have received.

Federal Chancellor of Austria Sebastian Kurz and his four colleagues sent a letter to the President of the European Commission on Friday Ursula von der Leyenille and the President of the European Council Charles Michelille arguing that vaccine doses from pharmaceutical companies are not supplied equally to all EU Member States.

Kurz has previously hinted that some EU member states may have signed “secret agreements” with vaccine companies to obtain more vaccines than they would have been entitled to under EU agreements.

EU countries have agreed that coronary vaccines will be distributed in the Union’s joint procurement according to population. On Friday, however, Kurz noted that if the readings are compared, it appears that the amounts of vaccine received by different countries do not match the agreement.

At that time, the EU representative Stefan de Keersmaecker denied allegations of “backroom contracts”. According to him, the agreements may have been amended, but this has always been done in discussions with other member states.

“Member States can request more or less of any vaccine offered, and these are discussed among member countries. It is possible that, as a result of these discussions, a new distribution method has been agreed with the vaccine company, ”Stefan de Keersmaecker said.

The Austrian Ministry of Health also rejected Kurz’s allegations and reiterated the EU’s statement.

EU countries the lines have been cracking over vaccine purchases for a long time. This has been due in particular to difficulties in supplying vaccines.

Read more: EU countries’ lines in vaccine procurement have started to crack – “Finland is following what this is really about”

The EU has blamed production and supply problems for the slow pace of vaccination.

Read more: Commission von der Leyen: “We are tired of being a scapegoat” – Europe has received less than 10% of promised Astra Zeneca vaccines

Vaccines the disputed availability does not seem to be, at least immediately, for the better. On Saturday, the pharmaceutical company Astra Zeneca announced delays in obtaining coronavirus vaccines from the European Union. This was reported by the news agency AFP. According to the pharmaceutical company, the decrease in the number of vaccines available in Europe is due to production problems and export restrictions.

“Astra Zeneca is disappointed to announce a reduction in the number of coronavirus vaccines shipped to the European Union despite its tireless work to speed up production,” the company commented in a statement.

The company had previously warned of problems in its European supply chain “due to the lower-than-expected production volume of the production process”.

Astra Zeneca announced its intention to compensate for part of the production delay by importing vaccines manufactured elsewhere into Europe. About half of Astra Zeneca’s vaccines available in the EU in April-June would be produced outside Europe.

Astra Zeneca began delivering vaccines to the EU in February and aims to deliver 100 million doses of vaccine to the Union by mid-2021.

Earlier in February was toldthat Astra Zeneca will deliver only about half of the promised vaccine doses to the EU in April-June.

#Pharmaceutical #companies #Biontech #plans #partner #competitors #produce #billion #doses #vaccine #year #companys #CEO #fears #future #pandemics #worsen

Next Post

Leave a Reply

Your email address will not be published. Required fields are marked *